Topoisomerase II-alpha gene deletion is not frequent as its amplification in breast cancer. (Q53603097)

16 May 2018

title

Topoisomerase II-alpha gene deletion is not frequent as its amplification in breast cancer. (English)

1 reference

16 May 2018

author

Sehwan Han

2

1 reference

16 May 2018

author name string

Kyeongmee Park

1

1 reference

16 May 2018

Geum-Hee Gwak

3

1 reference

16 May 2018

Huyn-Jung Kim

4

1 reference

16 May 2018

Jungyeon Kim

5

1 reference

16 May 2018

Kyoung-Mee Kim

6

1 reference

16 May 2018

language of work or name

English

0 references

publication date

24 February 2006

1 reference

16 May 2018

Breast Cancer Research and Treatment

published in

1 reference

16 May 2018

volume

98

1 reference

16 May 2018

issue

3

1 reference

16 May 2018

page(s)

337-342

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1007/s10549-006-9170-7

exact match

0 references

cites work

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-006-9170-7

Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-006-9170-7

Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-006-9170-7

Amplification of a 280-Kilobase Core Region at the ERBB2 Locus Leads to Activation of Two Hypothetical Proteins in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-006-9170-7

10.1007/S10549-006-9170-7

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018